Biotech

All Articles

Genentech to finalize cancer immunology research department

.Genentech will definitely close its cancer cells immunology research division, and also device head...

Kezar loses strong cyst but to confirm its worth in phase 1 test

.Kezar Life Sciences is actually dropping its dim phase 1 solid lump drug as the biotech goes all-in...

Acelyrin loses izokibep, dismisses 3rd of personnel

.In spite of izokibep maintaining its own newfound winning streak in the clinic, Acelyrin is actuall...

Rivus' period 2 obesity-related cardiac arrest test reaches endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medicine appl...

Ovid stops preclinical work, IV plan after soticlestat neglect

.Ovid Rehab actually exposed final month that it was actually trimming its head count as the firm na...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has actually opened up a $700 thousand R&ampD center in the Boston Seaport, increasing it...

Boundless Biography produces 'moderate' layoffs 5 months after $100M IPO

.Merely 5 months after getting a $100 thousand IPO, Vast Bio is actually laying off some employees a...

Halda's $126M will evolve 'keep as well as kill' cyst drugs

.The first stages of oncology R&ampD aren't short of fascinating brand new methods, and also Halda T...

Lykos 'disappointments' certainly not divulging study transgressions along with publisher

.Psychopharmacology has drawn 3 posts about midstage medical trial data assessing Lykos Rehabs' inve...

Analysts examine Avidity's DMD gain, revealing distinctions in information

.Avidity Biosciences satisfied real estate investors along with period 1/2 data in Duchenne muscular...